|
Treatment Options
|
N-methyl-D-aspartate Antagonists
These medications block the amino acid, glutamate, in the body that is thought to be responsible for the symptoms seen in Alzheimer?s patients. Memantine was approved for the treatment of moderate to severe dementia associated with Alzheimer?s disease, and therefore may be beneficial even for patients in later stages of Alzheimer's disease. In clinical studies, memantine was shown to help Alzheimer's patients improve performance of activities of daily living and thinking abilities. Drugs in the class
Memantine (Namenda) |
Note: The above information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist, or other healthcare professional. It is not intended to diagnose a health condition, but it can be used as a guide to help you decide if you should seek professional treatment or to help you learn more about your condition once it has been diagnosed.
|
